U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

JOSEPHPREZIOSO/AFPviaGettyImagesLONDON—TheU.K.’scost-effectivenesswatchdogsaidThursdayitisnotyetreco ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri




fashion

author:hotspot    Page View:477
Adobe

It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

Or is there?

advertisement

A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In